Scientists have identified a drug that could be a game-changer for patients. Istradefylline, which is already approved for Parkinson's disease, could reduce not only the harmful effects of cisplatin but also improve its anti-tumour properties.
Los Angeles [US], December 7 (ANI ): A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialised way, activating immune cells to fight cancer, according to a study led by Cedars-Sinai Cance